Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms-Reference-Cited by-同舟云学术

Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms

Published:2019-10-25 Issue:12 Volume:18 Page:1171-1189
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Buccheri Sergio¹,Capodanno Davide²,James Stefan¹,Angiolillo Dominick J.³

Affiliation:

1. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

2. Division of Cardiology, C.A.S.T., P.O. “G. Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy

3. Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1680637

Reference137 articles.

1. Mechanisms of Plaque Formation and Rupture

2. Acute Coronary Syndromes

3. Basic Principles of Platelet Biology and Clinical Implications

4. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

5. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

2. Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?;Journal of Cardiology;2024-08

3. Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management;Expert Opinion on Drug Safety;2023-12-02

4. Comparison of Ticagrelor Monotherapy and Ticagrelor Plus Aspirin Among Patients With Acute Coronary Syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Retrospective Cohort Study;Journal of Cardiovascular Pharmacology;2023-09-29

5. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios;Journal of Clinical Medicine;2023-09-13